Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
Scope of the Report:
The rising prevalence of cardiovascular diseases (CVDs), advancements in technology, and increasing investments in R&D are some of the factors that will propel growth in the cardiopulmonary Autotransfusion systems market in the Americas during the forecast period.
Cardiac surgeries are complex and may result in a significant loss of blood during deep surgical incisions. This can lower the balance of blood in the body and increase the risks of surgery-induced anemia in people after surgery. This leads to the demand for significant volumes of blood supply, which depends on the complexity of the surgery.
The worldwide market for Cardiopulmonary Autotransfusion System is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 590 million US$ in 2024, from 510 million US$ in 2019, according to a new GIR (Global Info Research) study.
Table of Contents
1 Market Overview
1.1 Cardiopulmonary Autotransfusion System Introduction
1.2 Market Analysis by Type
1.2.1 Unwashed ATS
1.2.2 Washed ATS
1.3 Market Analysis by Applications
1.3.1 Heart Surgery
1.3.2 Great Organ Transplant Surgery
1.3.3 Other Surgery
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
220.127.116.11 United States Market States and Outlook (2014-2024)
18.104.22.168 Canada Market States and Outlook (2014-2024)
22.214.171.124 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
126.96.36.199 Germany Market States and Outlook (2014-2024)
188.8.131.52 France Market States and Outlook (2014-2024)
184.108.40.206 UK Market States and Outlook (2014-2024)
220.127.116.11 Russia Market States and Outlook (2014-2024)
18.104.22.168 Italy Market States and Outlook (2014-20 ...